Air Liquide Pre-Q3 2023 Sales Communication Document Available

1 Mins read

Air Liquide (Paris:AI) announces today that its Pre-Q3 2023 sales communication document is available on the company’s corporate website under the “Investors” section. This quarterly document aims to assist in the financial modeling of the Group’s performance.

The Q3 2023 revenue will be published on October 25, 2023.

About Air Liquide

Air Liquide is a world leader in gases, technologies, and services for Industry and Health. With a presence in 73 countries, approximately 67,100 employees, and serving more than 3.9 million customers and patients, Air Liquide plays a crucial role in providing essential small molecules like oxygen, nitrogen, and hydrogen for various aspects of life, matter, and energy. These molecules have been at the core of Air Liquide’s activities since its inception in 1902.

Strategy and Goals

Taking action today while preparing for the future is at the heart of Air Liquide’s strategy. With its strategic plan for 2025, called ADVANCE, Air Liquide aims to achieve global performance by combining financial and extra-financial dimensions. The company is focused on exploring new markets and leveraging its business model’s resilience and strength, as well as its ability to innovate and technological expertise. In line with its commitment to sustainability and the environment, Air Liquide develops solutions that contribute to climate and energy transitions, particularly with hydrogen. It also strives to make advancements in areas such as healthcare, digitalization, and high technologies.

Financial Highlights

In 2022, Air Liquide’s revenue exceeded 29.9 billion euros. The company is listed on the Euronext Paris stock exchange (compartment A) and is part of prestigious indexes like CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good, and DJSI Europe.

For more information, please visit the Air Liquide website at

Related posts

Replimune Group's RP1 Clinical Trial Falls Short

1 Mins read
Replimune Group, a clinical-stage biotechnology company, has announced that its clinical trial evaluating the efficacy of RP1 as a treatment for cutaneous…

GitLab Stock Surges on First Ever Adjusted Operating Profit

1 Mins read
GitLab’s stock experienced a significant surge on Tuesday following the announcement of its first ever adjusted operating profit. Despite this positive development,…

Virgin Galactic Faces Stock Decline Amid Founder's Money Decision

2 Mins read
Virgin Galactic stock experienced a sharp decline in early trading on Monday due to founder Richard Branson’s announcement that he won’t be…

Leave a Reply

Your email address will not be published. Required fields are marked *

− 9 = 1